R&D Approach
Unique Database Target Discovery Target Validation Therapeutic Development Publications
Pipeline
Partnering
About us
Company Network Clinical Partners News & Media Career

What are you searching for?

R&D Approach Unique Database Target Discovery Target Validation Therapeutic Development Publications
Pipeline
Partnering
About us Company Network Clinical Partners News & Media Career

Home ›
›
News & Media ›
Multi Omic Characterization Molecular Subtype 1 Colorectal Cancer

Share this page

www.indivumed.com/literature/multi-omic-characterization-molecular-subtype-1-colorectal-cancer/

Via E-Mail Copy link

July 11, 2025

Multi-omic characterization of consensus molecular subtype 1 (CMS1) colorectal cancer with dampened immune response improves precision medicine

Indivumed on

Our Expertise

R&D Approach
Pipeline
Partnering

About Indivumed

Company
Career

Current Information

Publications
News & Media
Events

More Links

Omics Hub
Onco AI-Med
Contact

Imprint Legal Notice Data Protection Policy Ethical Principles

ⓒ 2025 Indivumed GmbH. All rights reserved.